615 related articles for article (PubMed ID: 29580896)
21. Harnessing impaired energy metabolism in cancer cell: small molecule- mediated ways to regulate tumorigenesis.
Govardhan KS; Ramyasri K; Kethora D; Ravishekar Y; Prasenjit M
Anticancer Agents Med Chem; 2011 Mar; 11(3):272-9. PubMed ID: 21434854
[TBL] [Abstract][Full Text] [Related]
22. 3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
Konstantakou EG; Voutsinas GE; Velentzas AD; Basogianni AS; Paronis E; Balafas E; Kostomitsopoulos N; Syrigos KN; Anastasiadou E; Stravopodis DJ
Mol Cancer; 2015 Jul; 14():135. PubMed ID: 26198749
[TBL] [Abstract][Full Text] [Related]
23. The Warburg effect in 2012.
Bayley JP; Devilee P
Curr Opin Oncol; 2012 Jan; 24(1):62-7. PubMed ID: 22123234
[TBL] [Abstract][Full Text] [Related]
24. Targeting the Mitochondrial Metabolic Network: A Promising Strategy in Cancer Treatment.
Frattaruolo L; Brindisi M; Curcio R; Marra F; Dolce V; Cappello AR
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825551
[TBL] [Abstract][Full Text] [Related]
25. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.
Du W; Amarachintha S; Wilson AF; Pang Q
Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373
[TBL] [Abstract][Full Text] [Related]
26. Effect of Mutant p53 Proteins on Glycolysis and Mitochondrial Metabolism.
Eriksson M; Ambroise G; Ouchida AT; Lima Queiroz A; Smith D; Gimenez-Cassina A; Iwanicki MP; Muller PA; Norberg E; Vakifahmetoglu-Norberg H
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993478
[No Abstract] [Full Text] [Related]
27. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
28. Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype.
Ganapathy-Kanniappan S
Crit Rev Biochem Mol Biol; 2018 Dec; 53(6):667-682. PubMed ID: 30668176
[TBL] [Abstract][Full Text] [Related]
29. Clinical development of cancer therapeutics that target metabolism.
Clem BF; O'Neal J; Klarer AC; Telang S; Chesney J
QJM; 2016 Jun; 109(6):367-72. PubMed ID: 26428335
[TBL] [Abstract][Full Text] [Related]
30. Role of multifaceted regulators in cancer glucose metabolism and their clinical significance.
Zhao L; Mao Y; Zhao Y; Cao Y; Chen X
Oncotarget; 2016 May; 7(21):31572-85. PubMed ID: 26934324
[TBL] [Abstract][Full Text] [Related]
31. Cancer cell metabolism: implications for therapeutic targets.
Jang M; Kim SS; Lee J
Exp Mol Med; 2013 Oct; 45(10):e45. PubMed ID: 24091747
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: targeting Warburg effect to fight cancer.
Zawacka-Pankau J; Grinkevich VV; Hünten S; Nikulenkov F; Gluch A; Li H; Enge M; Kel A; Selivanova G
J Biol Chem; 2011 Dec; 286(48):41600-41615. PubMed ID: 21862591
[TBL] [Abstract][Full Text] [Related]
33. Targeting glucose metabolism: an emerging concept for anticancer therapy.
Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
Am J Clin Oncol; 2011 Dec; 34(6):628-35. PubMed ID: 20805739
[TBL] [Abstract][Full Text] [Related]
34. Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK.
Moldogazieva NT; Mokhosoev IM; Terentiev AA
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32252351
[TBL] [Abstract][Full Text] [Related]
35. Targeting autophagy to overcome drug resistance in cancer therapy.
Kumar A; Singh UK; Chaudhary A
Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
[TBL] [Abstract][Full Text] [Related]
36. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
37. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
Smolková K; Plecitá-Hlavatá L; Bellance N; Benard G; Rossignol R; Ježek P
Int J Biochem Cell Biol; 2011 Jul; 43(7):950-68. PubMed ID: 20460169
[TBL] [Abstract][Full Text] [Related]
38. Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.
Ooi AT; Gomperts BN
Clin Cancer Res; 2015 Jun; 21(11):2440-4. PubMed ID: 25838393
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.
Chen JQ; Russo J
Biochim Biophys Acta; 2012 Dec; 1826(2):370-84. PubMed ID: 22750268
[TBL] [Abstract][Full Text] [Related]
40. The Warburg Effect: Historical Dogma Versus Current Rationale.
Vaupel P; Multhoff G
Adv Exp Med Biol; 2021; 1269():169-177. PubMed ID: 33966213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
